Dynavax Technologies
Dynavax Technologies is an Emeryville, California-based biopharmaceutical company founded in 1996 that develops and commercializes vaccines, including HEPLISAV-B for hepatitis B and the CpG 1018 vaccine adjuvant. It became a Sanofi subsidiary in February 2026.
Key facts
| Business Model | Commerce |
|---|---|
| CAGE Code | 4BYD4 |
| Legal Name | Dynavax Technologies Corporation |
| Company Operating Status | Acquired |
| Full Address | 2100 Powell Street, Suite 900 Emeryville, CA 94608 |
| Stock Symbol | DVAX |
| Ticker Symbol | DVAX |
| Wellfound ID | dynavax-technologies |
| Wikidata ID | Q30281797 |
Contact details
Email and phone for Dynavax Technologies are available to signed-in members of CliffBio.
Sign in to view